pargyline has been researched along with Hypertension, Essential in 2 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
MIZGALA, HF | 1 |
BARRERAARENAS, F | 1 |
1 review available for pargyline and Hypertension, Essential
Article | Year |
---|---|
NEWER DRUGS IN THE TREATMENT OF HYPERTENSION.
Topics: Antihypertensive Agents; Bretylium Compounds; Chlorothiazide; Chlorthalidone; Diuretics; Drug Therap | 1965 |
1 other study available for pargyline and Hypertension, Essential
Article | Year |
---|---|
[CLINICAL TRIAL WITH THE COMBINATION OF PARGYLINE AND METHYCLOTHIAZIDE IN THE TREATMENT OF ESSENTIAL ARTERIAL HYPERTENSION].
Topics: Drug Therapy; Essential Hypertension; Humans; Hypertension; Methyclothiazide; Pargyline | 1965 |